Chronotherapy for asthma reveals that afternoon inhaled corticosteroids significantly improve lung function and reduce ...

Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.

Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says.

Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody ...

The patients affected are those covered in Illinois, Texas, Oklahoma, New Mexico, and Montana, but not those with Medicare or Medicaid, the insurance giant says. Those five states are included in a ...

Changing time of day for taking asthma medication could improve symptoms – study - A dose from a preventer inhaler between ...

Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.

The French drug maker reported preliminary results from the TIDE-Asthma phase 2 study of amlitelimab and its efficacy in heterogeneous inflammatory asthma. Here’s what we know: Separately ...

Drilling down into subgroups of patients, Sanofi also claimed that amlitelimab demonstrated “compelling efficacy” in patients with heterogeneous inflammatory asthma. This would “potentially represent ...

Asthma management is very personalized. Find out what goes into to an asthma action plan and how medications are prescribed ...

Intellectual disabilities, food allergies, and asthma were all more common in children who took multiple courses of ...

On Tuesday, BCBS began mandating that severe asthma patients self-administer their drugs at home, unless their provider gets prior approval from the insurance company. The patients affected are ...